Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yuichiro Ohe

EGFR Mutation, but Not Sex and Smoking, Is Independently Associated With Favorable Prognosis of Gefitinib-Treated Patients With Lung Adenocarcinoma

Japanese Journal of Lung Cancer

English

Related publications

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

English

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal

2020

English

P2.03-030 Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated With EGFR-TKIs

Journal of Thoracic Oncology

English

SIRT1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma

OncoTargets and Therapy

Oncology

Pharmacology

2015

English

EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival

English

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma

English

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Experimental and Therapeutic Medicine

English

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity

Japanese Journal of Lung Cancer

English

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yuichiro Ohe

EGFR Mutation, but Not Sex and Smoking, Is Independently Associated With Favorable Prognosis of Gefitinib-Treated Patients With Lung Adenocarcinoma

Related publications

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

P2.03-030 Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated With EGFR-TKIs

SIRT1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma

EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma

Erlotinib Has Better Efficacy Than Gefitinib in Adenocarcinoma Patients Without EGFR-activating Mutations, but Similar Efficacy in Patients With EGFR-activating Mutations

Multiple Primary Lung Cancers Containing Adenocarcinoma With EGFR Gene Mutation and Adenocarcinoma With Strong PD-L1 Positivity

Predictive Factors in Patients With EGFR Mutation‑negative Non‑small Cell Lung Cancer Treated With Erlotinib